Revolutionizing Clinical Trials: A Manifesto for AI-Driven Transformation
- URL: http://arxiv.org/abs/2506.09102v1
- Date: Tue, 10 Jun 2025 15:45:19 GMT
- Title: Revolutionizing Clinical Trials: A Manifesto for AI-Driven Transformation
- Authors: Mihaela van der Schaar, Richard Peck, Eoin McKinney, Jim Weatherall, Stuart Bailey, Justine Rochon, Chris Anagnostopoulos, Pierre Marquet, Anthony Wood, Nicky Best, Harry Amad, Julianna Piskorz, Krzysztof Kacprzyk, Rafik Salama, Christina Gunther, Francesca Frau, Antoine Pugeat, Ramon Hernandez,
- Abstract summary: This manifesto represents a collaborative vision forged by leaders in pharmaceuticals, consulting firms, clinical research, and AI.<n>It outlines a roadmap for two AI technologies - causal inference and digital twins - to transform clinical trials, delivering faster, safer, and more personalized outcomes for patients.
- Score: 28.619499555811363
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: This manifesto represents a collaborative vision forged by leaders in pharmaceuticals, consulting firms, clinical research, and AI. It outlines a roadmap for two AI technologies - causal inference and digital twins - to transform clinical trials, delivering faster, safer, and more personalized outcomes for patients. By focusing on actionable integration within existing regulatory frameworks, we propose a way forward to revolutionize clinical research and redefine the gold standard for clinical trials using AI.
Related papers
- Over-Relying on Reliance: Towards Realistic Evaluations of AI-Based Clinical Decision Support [12.247046469627554]
We advocate for moving beyond evaluation metrics like Trust, Reliance, Acceptance, and Performance on the AI's task.<n>We call on the community to prioritize ecologically valid, domain-appropriate study setups that measure the emergent forms of value that AI can bring to healthcare professionals.
arXiv Detail & Related papers (2025-04-10T03:28:56Z) - Towards Regulatory-Confirmed Adaptive Clinical Trials: Machine Learning Opportunities and Solutions [59.28853595868749]
We introduce two new objectives for future clinical trials that integrate regulatory constraints and treatment policy value for both the entire population and under-served populations.<n>We formulate Randomize First Augment Next (RFAN), a new framework for designing Phase III clinical trials.<n>Our framework consists of a standard randomized component followed by an adaptive one, jointly meant to efficiently and safely acquire and assign patients into treatment arms during the trial.
arXiv Detail & Related papers (2025-03-12T10:17:54Z) - Medchain: Bridging the Gap Between LLM Agents and Clinical Practice through Interactive Sequential Benchmarking [58.25862290294702]
We present MedChain, a dataset of 12,163 clinical cases that covers five key stages of clinical workflow.<n>We also propose MedChain-Agent, an AI system that integrates a feedback mechanism and a MCase-RAG module to learn from previous cases and adapt its responses.
arXiv Detail & Related papers (2024-12-02T15:25:02Z) - Clinical Evaluation of Medical Image Synthesis: A Case Study in Wireless Capsule Endoscopy [63.39037092484374]
Synthetic Data Generation based on Artificial Intelligence (AI) can transform the way clinical medicine is delivered.<n>This study focuses on the clinical evaluation of medical SDG, with a proof-of-concept investigation on diagnosing Inflammatory Bowel Disease (IBD) using Wireless Capsule Endoscopy (WCE) images.<n>The results show that TIDE-II generates clinically plausible, very realistic WCE images, of improved quality compared to relevant state-of-the-art generative models.
arXiv Detail & Related papers (2024-10-31T19:48:50Z) - Digital Twin Ecosystem for Oncology Clinical Operations [0.8130739369606821]
This paper introduces a novel digital twin framework specifically designed to enhance oncology clinical operations.
We propose the integration of multiple specialized digital twins, such as the Medical Necessity Twin, Care Navigator Twin, and Clinical History Twin.
By synthesizing multiple data sources and aligning them with the National Comprehensive Cancer Network (NCCN) guidelines, we create a dynamic Cancer Care Path.
arXiv Detail & Related papers (2024-09-26T08:56:54Z) - Establishing Rigorous and Cost-effective Clinical Trials for Artificial Intelligence Models [18.240773244542474]
A profound gap persists between artificial intelligence (AI) and clinical practice in medicine.
State-of-the-art and state-of-the-practice AI model evaluations are limited to laboratory studies on medical datasets or direct clinical trials with no or solely patient-centered controls.
For the first time, we emphasize the critical necessity for rigorous and cost-effective evaluation methodologies for AI models in clinical practice.
arXiv Detail & Related papers (2024-07-11T14:37:08Z) - AI Hospital: Benchmarking Large Language Models in a Multi-agent Medical Interaction Simulator [69.51568871044454]
We introduce textbfAI Hospital, a framework simulating dynamic medical interactions between emphDoctor as player and NPCs.
This setup allows for realistic assessments of LLMs in clinical scenarios.
We develop the Multi-View Medical Evaluation benchmark, utilizing high-quality Chinese medical records and NPCs.
arXiv Detail & Related papers (2024-02-15T06:46:48Z) - FUTURE-AI: International consensus guideline for trustworthy and deployable artificial intelligence in healthcare [73.78776682247187]
Concerns have been raised about the technical, clinical, ethical and legal risks associated with medical AI.
This work describes the FUTURE-AI guideline as the first international consensus framework for guiding the development and deployment of trustworthy AI tools in healthcare.
arXiv Detail & Related papers (2023-08-11T10:49:05Z) - A Revolution of Personalized Healthcare: Enabling Human Digital Twin
with Mobile AIGC [54.74071593520785]
Mobile AIGC can be a key enabling technology for an emerging application, called human digital twin (HDT)
HDT empowered by the mobile AIGC is expected to revolutionize the personalized healthcare by generating rare disease data, modeling high-fidelity digital twin, building versatile testbeds, and providing 24/7 customized medical services.
arXiv Detail & Related papers (2023-07-22T15:59:03Z) - OpenClinicalAI: enabling AI to diagnose diseases in real-world clinical
settings [11.287929392365756]
We build a clinical AI benchmark named Clinical AIBench to set up real-world clinical settings to facilitate researches.
We propose an open, dynamic machine learning framework and develop an AI system named OpenClinicalAI to diagnose diseases in real-world clinical settings.
In the real-world clinical setting, OpenClinicalAI significantly outperforms the state-of-the-art AI system.
arXiv Detail & Related papers (2021-09-09T02:59:36Z) - Reflections on the Clinical Acceptance of Artificial Intelligence [15.594759364908235]
This chapter reflects on the use of Artificial Intelligence (AI) and its acceptance in clinical environments.
We develop a general view of hindrances for clinical acceptance in the form of a pipeline model combining AI and clinical practise.
arXiv Detail & Related papers (2021-03-01T17:34:09Z) - Review of Artificial Intelligence Techniques in Imaging Data
Acquisition, Segmentation and Diagnosis for COVID-19 [71.41929762209328]
The pandemic of coronavirus disease 2019 (COVID-19) is spreading all over the world.
Medical imaging such as X-ray and computed tomography (CT) plays an essential role in the global fight against COVID-19.
The recently emerging artificial intelligence (AI) technologies further strengthen the power of the imaging tools and help medical specialists.
arXiv Detail & Related papers (2020-04-06T15:21:34Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.